Matthew E. Korenberg, VP, Finance and CFO at LIGAND PHARMACEUTICALS INC (LGND), sold 13,118 shares at $142.63 ($1.9M) on 2017-11-17, disclosed to the SEC on 2017-11-17.
Open-market sale of $1.9M LGND by VP, Finance and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.63 | 6,559 | $936K | 50.0% |
| 2 | $142.63 | 6,559 | $936K | 50.0% |
| Total | $142.63 avg | 13,118 | $1.9M | 100% |
| Filing → |
| LGND | SELL | 2024-08-13 | $3.6M | — | Filing → |
| LGND | SELL | 2024-05-15 | $2.9M | — | Filing → |
| LGND | BUY | 2019-09-03 | $43K | — | Filing → |